BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CorMedix 

86 Summit Avenue
Suite 301
Summit  New Jersey  07901  U.S.A.
Phone: 908-517-9500 Fax: 908-522-9199


SEARCH JOBS










 Company News
CorMedix (CRMD) Files Request With FDA For QIDP Designation For Neutrolin 12/4/2014 12:55:52 PM
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014 11:10:20 AM
CorMedix (CRMD) To Announce Third Quarter 2014 Results On November 13, 2014; Conference Call Hosted At 9 Am On Friday, November 14, 2014 11/7/2014 8:05:18 AM
CorMedix (CRMD) Receives Approval From FDA To Initiate A Clinical Trial For Neutrolin In The U.S. 10/27/2014 10:21:12 AM
CorMedix (CRMD) Announces FDA IND Filing For Neutrolin® In United States 9/25/2014 8:27:01 AM
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014 8:50:51 AM
CorMedix (CRMD) Amends And Restates Outstanding Securities To Remove Provisions Causing Derivative Liability Classification 9/16/2014 9:33:11 AM
FDA Accepts CorMedix (CRMD) Pivotal Phase 3 Study Protocol 8/15/2014 8:25:17 AM
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing 7/24/2014 11:05:55 AM
CorMedix (CRMD) Finalizes Pivotal Phase 3 Study Protocol For FDA 6/24/2014 6:31:58 AM
12345678